Anacor Pharmaceuticals Announces Positive Preliminary Results from Phase IIb Trial

Anacor Pharmaceuticals announced today preliminary results from its Phase IIb trial of AN2728 for the treatment of mild-to-moderate plaque-type psoriasis.
MarketWatch